Siponimod May Delay Wheelchair Use in Secondary Progressive MS Siponimod May Delay Wheelchair Use in Secondary Progressive MS

A post hoc analysis from the EXPAND trial suggests further slowing of disability progression, but an extrapolation by the researchers out to 16 years was criticized as"speculative."Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news